HRS-7058
HRS-7058-205
Phase 2 small_molecule active
Quick answer
HRS-7058 for Pancreatic Cancer is a Phase 2 program (small_molecule) at Shandong Suncadia Medicine Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shandong Suncadia Medicine Co.,
- Indication
- Pancreatic Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active